SCHEMBL25322018

SCHEMBL25322018

Cc1ccc(Cl)c(C=O)c1O

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
CYP3A4 P08684 2/20 0.38
MAPT P10636 1/20 0.38
PADI4 Q9UM07 1/20 0.36
ERN1 O75460 8/20 0.36
AR P10275 2/20 0.34
DPP4 P27487 1/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
HPGD P15428 1/20 0.33
AOX1 Q06278 1/20 0.33
ALB P02768 1/20 0.33
USP2 O75604 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1678698 0.83 ALDH1A1 (0.41) ALDH1A1MEN1KMT2ATDP1CYP3A4
SCHEMBL29955992 0.83 ALDH1A1 (0.41) ALDH1A1MEN1KMT2ATDP1CYP3A4
SCHEMBL29397237 0.82 CYP3A4 (0.42) ALDH1A1MEN1KMT2ATDP1CYP3A4
SCHEMBL3966986 0.82 CYP3A4 (0.42) ALDH1A1MEN1KMT2ATDP1CYP3A4
SCHEMBL30892256 0.82 ALDH1A1 (0.54) ALDH1A1MEN1KMT2ATDP1CYP3A4
SCHEMBL659499 0.82 ALDH1A1 (0.54) ALDH1A1MEN1KMT2ATDP1CYP3A4
SCHEMBL30892258 0.82 ALDH1A1 (0.54) ALDH1A1MEN1KMT2ATDP1CYP3A4
SCHEMBL14577383 0.78 ERN1 (0.46) ALDH1A1CYP3A4MAPTPADI4ERN1
SCHEMBL841552 0.78 CYP3A4 (0.48) ALDH1A1CYP3A4MAPTPADI4ERN1
SCHEMBL909851 0.78 ALDH1A1 (0.50) ALDH1A1MEN1KMT2ATDP1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250109148-A1 HETEROCYCLIC GLP-1 AGONISTS SHANGHAI SHOUTI BIOTECHNOLOGY CO., LTD. (CN) 2025-04-03 US disclosed
CN-119343339-A Heterocyclic GLP-1 agonists 加舒布鲁姆生物公司 2025-01-21 CN disclosed
EP-4469444-A1 HETEROCYCLIC GLP-1 AGONISTS Gasherbrum Bio, Inc. (US) 2024-12-04 EP disclosed
WO-2023138684-A1 HETEROCYCLIC GLP-1 AGONISTS GASHERBRUM BIO , INC. (US) 2023-07-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250109148-A1 HETEROCYCLIC GLP-1 AGONISTS GLP1R, GIPR, GCGR ALDH1A1 1901/4885MEN1 450/4885KMT2A 3670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.